Evidence map›Paper›PMID 21664428›Full record

ReviewMolecular and cellular endocrinology2011

Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction.

Hichem Miraoui, Andrew Dwyer, Nelly Pitteloud

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. A case of novel mutation in ANOS1 (KAL1) gene and review of Kallmann syndrome.Endocrinology, diabetes & metabolism case reports · 2023
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. EMBO molecular medicine · 2017
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hichem MiraouiCentre Hospitalier Universitaire Vaudois, Endocrine, Diabetes, & Metabolism Service, BH 19-701, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Andrew Dwyer
Nelly Pitteloud
University Hospital of Lausanne · CH

Funding

The role of FGF signaling in neuroendocrine control of reproductionR01HD056264 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI PITTELOUD, NELLY · 2008 to 2012
$1.8M
NICHD NIH HHS R01 HD056264
6 · The paper itself

Abstract

Fibroblast growth factor (FGF) signaling is critical for a broad range of developmental processes. In 2003, Fibroblast growth factor receptor 1 (FGFR1) was discovered as a novel locus causing both forms of isolate GnRH Deficiency, Kallmann syndrome [KS with anosmia] and normosmic idiopathic hypogonadotropic hypogonadism [nIHH] eventually accounting for approximately 10% of gonadotropin-releasing hormone (GnRH) deficiency cases. Such cases are characterized by a broad spectrum of reproductive phenotypes from severe congenital forms of GnRH deficiency to reversal of HH. Additionally, the variable expressivity of both reproductive and non-reproductive phenotypes among patients and family members harboring the identical FGFR1 mutations has pointed to a more complex, oligogenic model for GnRH deficiency. Further, reversal of HH in patients carrying FGFR1 mutations suggests potential gene-environment interactions in human GnRH deficiency disorders.

Indexed as

Fibroblast Growth FactorsGene-Environment InteractionHumansMutationNeurosecretory SystemsPhenotypeReproductionFibroblast Growth Factors

Identifiers

PMID21664428
PMCPMC3185130
OpenAlexW2006006799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.